BRKR: Barclays Raises Target
Barclays maintains overweight rating on Bruker and raises price target to $60
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Barclays maintains overweight rating on Bruker and raises price target to $60
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.